naltrexone has been researched along with ly 255582 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantrell, BE; Johnson, BG; Leander, JD; Mendelsohn, LG; Mitch, CH; Reel, JK; Shaw, WN; Snoddy, JD; Takemori, AE; Wong, DT | 1 |
Cantrell, BE; Carroll, FI; Dersch, CM; Mascarella, SW; McCullough, KB; Partilla, JS; Rothman, RB; Thomas, JB; Xu, H; Zimmerman, DM | 1 |
Carroll, FI | 1 |
Carroll, FI; Chaudhari, S; Deschamps, J; Gigstad, KM; Mascarella, SW; Navarro, HA; Thomas, JB | 1 |
Emmerson, PJ; Holloway, WG; Matt, JE; McKinzie, JH; Mitch, CH; Siegel, MG; Statnick, MA; Surface, PL; Suter, TM; Takeuchi, K; Thomas, EM; Wolfe, CN | 1 |
Emmerson, PJ; Holloway, WG; McKinzie, JH; Mitch, CH; Quimby, SJ; Siegel, MG; Statnick, MA; Surface, PL; Suter, TM; Takeuchi, K; Thomas, EM | 1 |
1 review(s) available for naltrexone and ly 255582
Article | Year |
---|---|
2002 Medicinal Chemistry Division Award address: monoamine transporters and opioid receptors. Targets for addiction therapy.
Topics: Animals; Biogenic Monoamines; Biological Transport; Carrier Proteins; Cocaine; Fluorescent Dyes; Humans; Isoquinolines; Ligands; Morphinans; Narcotic Antagonists; Piperidines; Protein Binding; Radioisotopes; Receptors, Opioid; Structure-Activity Relationship; Substance-Related Disorders | 2003 |
5 other study(ies) available for naltrexone and ly 255582
Article | Year |
---|---|
3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: opioid antagonists with potent anorectant activity.
Topics: Analgesia; Animals; Appetite Depressants; Cyclohexanes; Diuresis; Eating; Endorphins; Guinea Pigs; Male; Mice; Molecular Structure; Piperidines; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 1993 |
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.
Topics: Animals; Brain; Crystallography, X-Ray; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; In Vitro Techniques; Molecular Conformation; Narcotic Antagonists; Piperidines; Rats; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1998 |
N-substituted cis-4a-(3-hydroxyphenyl)-8a-methyloctahydroisoquinolines are opioid receptor pure antagonists.
Topics: Animals; Benzeneacetamides; CHO Cells; Cricetinae; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoquinolines; Models, Molecular; Molecular Conformation; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2005 |
Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Drug Design; Ethers; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Molecular Conformation; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2007 |
Structure activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 2.
Topics: Acrylic Resins; Amides; Carboxylic Acids; Ethers; Molecular Structure; Narcotic Antagonists; Receptors, Opioid; Structure-Activity Relationship | 2007 |